Drug Emporium
This article was originally published in The Rose Sheet
Executive Summary
Drug and personal care retailer delisted from Nasdaq on close of trade March 14 following consecutive stock declines, firm announces. Beginning March 15, company's common stock listed on OTC Bulleting Board. Drug Emporium was warned in November that it would be delisted if its stock price did not rise above $1 for 10 consecutive days (1"The Rose Sheet" Nov. 27, 2000, In Brief)